<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02877407</url>
  </required_header>
  <id_info>
    <org_study_id>B-1605/345-002</org_study_id>
    <nct_id>NCT02877407</nct_id>
  </id_info>
  <brief_title>Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy for the Treatment of Uterovaginal Prolapse</brief_title>
  <acronym>PROLAPSE</acronym>
  <official_title>A Randomized Controlled Study of Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy for the Treatment of Uterovaginal Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      -  objective: aimed to compare laparoscopic/robot-assisted hysteropexy with vaginal&#xD;
           hysterectomy for uterine prolapse&#xD;
&#xD;
        -  prospective randomized clinical trial&#xD;
&#xD;
        -  patient&#xD;
&#xD;
             1. 60yrs or more women and&#xD;
&#xD;
             2. POP-Q stage II with symptom or POP-Q III, IV regardless of symptom&#xD;
&#xD;
        -  number of patient: 146&#xD;
&#xD;
        -  randomize: laparoscopic/robot-assisted hysteropexy vs. hysterectomy&#xD;
&#xD;
        -  follow up: postoperative 1 year&#xD;
&#xD;
        -  primary endpoint: recurrence rate&#xD;
&#xD;
             1. recurrence of uterovaginal prolapse POP-Q stage II-IV&#xD;
&#xD;
             2. recurrence of associated symptom&#xD;
&#xD;
        -  secondary endpoint&#xD;
&#xD;
             1. postoperative 1 year QOL, degree of satisfaction evaluation&#xD;
&#xD;
             2. operative time, estimated blood loss&#xD;
&#xD;
             3. hospitalization period, postoperative pain, return to normal activity&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence rate (%)</measure>
    <time_frame>postoperative 1 year</time_frame>
    <description>recurrence rate(%) of uterovaginal prolapse POP-Q stage II-IV in postoperative 1 year</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">146</enrollment>
  <condition>Uterovaginal Prolapse</condition>
  <condition>Hysteropexy</condition>
  <arm_group>
    <arm_group_label>laparoscopic/robotic-assisted hysteropexy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient who undergo laparoscopic/robotic-assisted hysteropexy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vaginal hysterectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient who undergo vaginal hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>patient who undergo laparoscopic/robotic-assisted hysteropexy</intervention_name>
    <arm_group_label>laparoscopic/robotic-assisted hysteropexy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>patient who undergo vaginal hysterectomy</intervention_name>
    <arm_group_label>vaginal hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  POP-Q stage II with symptom or POP-Q III, IV regardless of symptom&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  abnormal uterine bleeding&#xD;
&#xD;
          -  significantly enlarged fibroid uterus&#xD;
&#xD;
          -  postmenopausal uterine bleeding&#xD;
&#xD;
          -  endometrial pathology&#xD;
&#xD;
          -  on tamexifen&#xD;
&#xD;
          -  concomitant medical problems precluding general anesthesia or surgery&#xD;
&#xD;
          -  damaged agreement ability&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong Hun Suh, associate professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dong Hun Suh, associate professor</last_name>
    <email>sdhwcj@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National Univesity Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Kyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Hun Suh, associate professor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2016</study_first_posted>
  <last_update_submitted>August 24, 2016</last_update_submitted>
  <last_update_submitted_qc>August 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Dong Hoon Suh</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

